Blood thinners are one of the most used drugs. Especially many older white swallow the pills with names such as Warfarin or warfarin for the rest of their lives after being treated for heart arrhythmia or around a knee or hip surgery.
There has recently been a new generation of anti-clotting pills on the market and to prevent accidents happening in the introduction, have medical specialists and LabNoord in Groningen agreements in the Region Table anticoagulation.
For years look cardiologists, hematologists and their patients eagerly await a new generation of pills, called NOAC's New Anti-Coagulation. They are as good as the old one but friendlier to use. Patients with blood thinners should still have their monthly blood test to check the thrombosis or blood is not too thin or thick. The new pills which do not, there are fewer fluctuations. "For patients this is very nice and it is logical that many people themselves want the new blood thinners," says Ursula Young Boss of the Region Table.
But the new agents also have drawbacks. Thus, the risk of stomach bleeding is larger. And if there is a time bleeding occurs, there is no antidote. With the old generation blood thinners could still do, a quick antidote swallow to stop the bleeding. "There are fabrics in development that could serve as an antidote but they are not there yet," said Karina Meijer, hematologist at the UMCG.
The higher risk of stomach bleeding came two weeks ago in the news after several scientific studies. "But there is opposite that with these NOAC's is actually less risk of stroke," added Meyer. "It sounds harsh, but from a stomach hemorrhage your blood or death, or you recover fully. A stroke can have just unpleasant consequences in the longer term."
The advantage of the new resources that you do not have to prick blood is immediately also a major drawback. Patients therefore get no more to spend as much time at the Thrombosis; less well they "fit". "We must avoid a whole group NOAC users running around in the wild without anyone checking them," says De Jonge Baas.
Hence the agreements in the Region Table anticoagulation. Thrombosis is all patients who have been transferred to the NOAC's after a month call, whether they swallow their pills and if they liked it. "By the blood test could also see immediately whether people swallow. That you see no more."
For doctors to pay attention blown. The new pills are not suitable for all patients. But by word of mouth to ask many patients there to their doctor. "For now we agree that only people with heart rhythm disorders, venous thrombosis and pulmonary embolism after getting the new resources required."
In the hospital or at the dentist is also getting used to. The blood clotting different with the new pills and the physician must therefore also intervene in a different way in bleeding episodes. There are new protocols when patients withthe new means onthe operating table or end up in emergency assistance.